Antiviral drugs arbidol and interferon alpha-1b contribute to reducing the severity of COVID-19 patients: a retrospective cohort study

OBJECTIVES: The aim of this study was to evaluate the role of antiviral drugs in reducing the risk of developing severe illness in patients with moderate COVID-19 pneumonia. METHODS: This retrospective cohort study included 403 adult patients with moderate COVID-19 pneumonia who were admitted to She...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Peng, Meng, Juan, Chen, Jincheng, Gao, Junxiao, Wang, Dongqi, Liu, Shuyan, Guo, Qinglong, Zhu, Muchun, Zhang, Gengwei, Liu, Yingxia, Li, Ye, Zhang, Guoliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264997/
https://www.ncbi.nlm.nih.gov/pubmed/34238341
http://dx.doi.org/10.1186/s12985-021-01617-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264997/
https://www.ncbi.nlm.nih.gov/pubmed/34238341
http://dx.doi.org/10.1186/s12985-021-01617-w

Ejemplares similares